DPU Super Specialty Hospital and Mirayee Hospital Join Hands to Strengthen Liver Transplant Services

IMT News Desk
IMT News Desk
· 3 min read
DPU Super Specialty Hospital and Mirayee Hospital partner to strengthen liver transplant services in Western India with advanced care and expertise.

DPU Super Specialty Hospital, Pimpri, Pune and Mirayee Hospital, Mirayee Centre for Transplant Excellence, managed by Rela Hospital Pvt. Ltd., Chennai, have entered into a strategic Memorandum of Understanding to collaborate in the field of liver transplantation and advanced hepatobiliary care.

Under this collaboration, Mirayee Hospital will provide its specialized expertise, experienced transplant team and senior clinical leadership. At the same time, DPU Super Specialty Hospital will offer the necessary infrastructure, facilities and operational support to ensure seamless delivery of liver transplant services and related clinical care.

Speaking on the association, Dr. P. D. Patil, Chancellor, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, said, “Healthcare institutions carry a deep responsibility towards society, especially when it comes to highly specialized care such as organ transplantation. Our collaboration with Mirayee Hospital and Dr. Mohamed Rela is an important step in strengthening access to advanced liver transplant services in Western India. Through this partnership, we hope to offer patients and their families renewed confidence, timely care and the benefit of world-class medical expertise closer to home.”

Emphasising the hospital’s commitment to making advanced care accessible, Dr. Bhagyashree Patil, Pro-Chancellor, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune and Chairperson, DPU Super Specialty Hospital, Pimpri, Pune, said, “Our vision has always been to make advanced, world-class healthcare accessible to every patient. This collaboration with Mirayee Hospital marks a significant milestone in strengthening liver transplant services in the region. By combining our robust infrastructure and patient-centric approach with Mirayee Hospital’s unparalleled expertise in liver transplantation, we aim to create a centre of excellence that delivers comprehensive, high-quality liver care closer to home.”

Dr. Yashraj P. Patil, Trustee and Treasurer, Dr. D. Y. Patil Vidyapeeth, said, “Liver transplantation demands the highest level of clinical coordination, advanced infrastructure, technology and critical care support. At DPU Super Specialty Hospital, we have continuously invested in systems that support complex, multidisciplinary care. This collaboration brings together surgical expertise, technology-enabled care pathways and hospital infrastructure to create a stronger platform for advanced liver care. Our focus is to ensure that patients have access to safe, precise and comprehensive treatment under one integrated ecosystem.”

Dr. Mohamed Rela, Chairman and Managing Director, Rela Hospital and Founder and Director, Institute of Liver Disease and Transplantation, said, “We are excited about this partnership with DPU Super Specialty Hospital. Together, we look forward to strengthening access to advanced liver care and offering patients the benefit of clinical expertise, infrastructure and compassionate care.”

Through the combined strengths of DPU Super Specialty Hospital, Pimpri, Pune and Mirayee Hospital, the partnership is expected to create a robust platform for delivering comprehensive liver care, enhancing treatment outcomes and supporting patients and their families throughout the transplant journey.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk